$Karen Dineen Wagner, MD, PhD: Management of Treatment Refractory Attention-Deficit/Hyperactivity Disorder in Children and Adolescents$

Karen Dineen Wagner, MD, PhD: Management of Treatment Refractory Attention-Deficit/Hyperactivity Disorder in Children and Adolescents

Name: Karen Dineen Wagner, MD, PhD: Management of Treatment Refractory Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
SKU: 3260
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 36 No. 1 Articles Tags: bupropion, clonidine, dextroamphetamine, guanfacine, karen-dineen-wagner, medworks-media, methylphenidate, psychopharmacology-bulletin, psychostimulant, tricyclic-antidepressant

Description

Karen Dineen Wagner, MD, PhD: Management of Treatment Refractory Attention-Deficit/Hyperactivity Disorder in Children and Adolescents

Description

Karen Dineen Wagner, MD, PhD

GENERAL PSYCHOPHARMACOLOGY

Management of Treatment Refractory Attention-Deficit/Hyperactivity Disorder in Children and Adolescents

Karen Dineen Wagner, MD, PhD

Ramelteon for Insomnia Related to (ADHD) by Rachel E. Fargason

Clozapine Factors in Schizophrenia by Takefumi Suzuki

Monoarthritis Induced by Bupropion Hydrochloride by Barry N. Williams

Schizophrenia Rating Scales Critical Review by Takefumi Suzuki

Karen Dineen Wagner, MD, PhD: Management of Treatment Refractory Attention-Deficit/Hyperactivity Disorder in Children and Adolescents

Description

Karen Dineen Wagner, MD, PhD

GENERAL PSYCHOPHARMACOLOGY

Management of Treatment Refractory Attention-Deficit/Hyperactivity Disorder in Children and Adolescents

Karen Dineen Wagner, MD, PhD

Related products

Ramelteon for Insomnia Related to (ADHD) by Rachel E. Fargason

Clozapine Factors in Schizophrenia by Takefumi Suzuki

Monoarthritis Induced by Bupropion Hydrochloride by Barry N. Williams

Schizophrenia Rating Scales Critical Review by Takefumi Suzuki